Clinical trials
Completed Phase 2 trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
835 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 7 |
| 2002 | 9 |
| 2003 | 10 |
| 2004 | 30 |
| 2005 | 34 |
| 2006 | 41 |
| 2007 | 30 |
| 2008 | 43 |
| 2009 | 41 |
| 2010 | 51 |
| 2011 | 50 |
| 2012 | 34 |
| 2013 | 37 |
| 2014 | 33 |
| 2015 | 52 |
| 2016 | 37 |
| 2017 | 65 |
| 2018 | 37 |
| 2019 | 41 |
| 2020 | 33 |
| 2021 | 42 |
| 2022 | 25 |
| 2023 | 20 |
| 2024 | 15 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 835 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 47 |
| Rigshospitalet, Denmark | 40 |
| Novartis Pharmaceuticals | 34 |
| GlaxoSmithKline | 28 |
| University of Aarhus | 28 |
| Novo Nordisk A/S | 26 |
| Bayer | 21 |
| Boehringer Ingelheim | 21 |
| Hoffmann-La Roche | 20 |
| Bristol-Myers Squibb | 18 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 36 |
| Breast Neoplasms | 29 |
| Heart Failure | 21 |
| Pulmonary Disease, Chronic Obstructive | 21 |
| Asthma | 19 |
| Diabetes Mellitus | 19 |
| Renal Insufficiency, Chronic | 18 |
| Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Obesity | 14 |
Trials
Showing 1 to 25 of 835. Each trial links to its page on Pharma Observatory.
735 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.